Systemic therapy in advanced NSCLC in the older patient: a network audit of non small cell lung cancer patients

被引：0
|
作者：
Wilshaw, V. [1 ]
Das, T. [1 ]
Hatton, N. [1 ]
Fisher, P. M. [1 ]
Lee, C. E. [1 ]
Danson, S. J. [2 ]
Woll, P. J. [3 ]
Hatton, M. Q. [2 ]
机构：
[1] Weston Pk Hosp, Clin Oncol, Sheffield, S Yorkshire, England
[2] Weston Pk Hosp, Acad Unit Oncol, Sheffield, S Yorkshire, England
[3] Weston Pk Hosp, Acad Unit Oncol, Sheffield Canc Res Ctr, Sheffield, S Yorkshire, England
来源：
LUNG CANCER | 2015年 / 87卷
关键词：
D O I：
10.1016/S0169-5002(15)50084-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
85
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [31] CRIZOTINIB THERAPY FOR PATIENTS WITH ADVANCED ROS1-REARRANGED NON-SMALL CELL LUNG CANCER (NSCLC)
    Ou, Sai-Hong I.
    Kim, Dong-Wan
    Camidge, D. Ross
    Riely, Gregory
    Salgia, Ravi
    Shapiro, Geoffrey
    Solomon, Ben
    Engelman, Jeffrey A.
    Kwak, Eunice L.
    Clark, Jeffrey W.
    Tye, Lesley
    Wilner, Keith
    Usari, Tiziana
    Varella-Garcia, Marileila
    Bergethon, Kristin
    Iafrate, A. J.
    Shaw, Alice T.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S295 - S295
  • [32] Chemoradiation in older patients with stage III non-small cell lung cancer (NSCLC)
    Ng, Dawn M.
    Sun, Alex
    Coate, Linda
    Ma, Clement
    Bezjak, Andrea
    Brade, Anthony
    Burkes, Ronald L.
    Cho, John
    Feld, Ronald
    Liu, Geoff
    Shepherd, Frances
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S858 - S858
  • [33] Third-line therapy and beyond for patients with advanced/metastatic non-small cell lung cancer (NSCLC).
    Corral Jaime, Jesus
    Gonzalez de la Pena, Miriam
    Alonso, Miriam
    Sanchez Gastaldo, Amparo
    Dolores Mediano, Maria
    Amerigo, Marta
    Enrique Robles, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC): Outcomes from a community oncology network.
    Neubauer, M. A.
    Garey, J. S.
    Nelson, G. C.
    Patt, D. A.
    Cartwright, T. H.
    Hoverman, J. R.
    Busby, L. T.
    Brooks, B. D.
    Sitarik, M. A.
    Kolodziej, M. A.
    Anderson, R. W.
    Beveridge, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy
    Altundag, Ozden
    Stewart, David J.
    Fossella, Frank V.
    Ayers, Gregory D.
    Wei, Wei
    Zhou, Xian
    Zinner, Ralph G.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (02) : 141 - 146
  • [36] Measures of aggressive care in advanced non-small cell lung cancer (NSCLC) patients
    McCannon, J.
    Jackson, V. A.
    Billings, J. A.
    Pirl, W. F.
    Greer, J.
    Lynch, T. J.
    Temel, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] FUNCTIONAL DECLINE IN PATIENTS WITH ADVANCED STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Murnane, A.
    Krishnasamy, M.
    Denehy, L.
    Granger, C.
    Aranda, S.
    Mileshkin, L.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S27 - S28
  • [38] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [39] INDIVIDUALIZED CHEMOTHERAPY (CT) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Obodnikov, Oleksandr O.
    Orlovsriy, Oleksiy A.
    Parshikov, Oleksandr V.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1280 - S1281
  • [40] Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
    Chang, V. T.
    Hoover, D. R.
    Cogswell, J.
    Cholankeril, M.
    Badin, S.
    Yang, W.
    Yan, H.
    Gonzalez, M. L.
    Einhorn, J.
    Kasimis, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345